RCC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
RCC
May 12, 2024, 07:40 |
Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
Apr 30, 2024, 11:10 |
Blog
Mohammad Jad Moussa: Proud of Stefan Maksimović, finalist for tripartite 'Lawrence Family Bone Disease Prog of Texas' Awards
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Apr 26, 2024, 19:38 |
Opinion
Pedro C Barata: Our work on transcriptomic profiles in RCC
Pedro C Barata, Medical Oncologist at University Hospitals Seidman Cancer Center, posted on X/Twitter: "Happy…
Apr 23, 2024, 16:11 |
Blog
Laura Bukavina: Congrats on the award for top poster at IKCSEU24
Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared on X:…
Apr 22, 2024, 15:26 |
Blog
Olubukola Ayodele: Attending the IKCS Europe 2024 conference in the picturesque seaside town of Sitges
Olubukola Ayodele, Consultant Medical Oncologist at Leicester Cancer Research Centre, shared on LinkedIn: "I'm currently attending…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 16, 2024, 13:08 |
Blog
Shilpa Gupta: Great to have Yousef Zakharia, UI Holden Comprehensive Cancer Center talk about updates in kidney cancer
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter: ''Great…
Apr 14, 2024, 03:52 |
Drugs
Piotr Wysocki: CLEAR trial – another study demonstrating that Immunotherapy and TKI combination should not be routinely recommended to favorable-risk RCC patients
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 8, 2024, 22:02 |
Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 25, 2024, 16:15 |
Insight
Piotr Wysocki: Stereotactic ablative body radiotherapy of primary tumor is highly active in patients with localized renal cell cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
1
2
All:
13
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube